A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1992
11/19/1992	EP0192660B1 Absorption enhancing agents
11/19/1992	EP0185759B1 Electrolyte solutions and (in vivo) use thereof
11/19/1992	DE4116400A1 Injection solns. contg. non-steroidal antiphlogistic substances - for local treatment of acute, sub-acute and chronic recidivist pains of rheumatic or non-rheumatic origin
11/19/1992	DE4116123A1 Skin diseases treatment agent - contains 2-hydroxy-5-methyl-lauro-phenone oxime combined with natural hydrating agents, moisturisers and/or penetration promoters
11/19/1992	DE4116004A1 Naehrstoffzubereitung Naehrstoffzubereitung
11/18/1992	WO1992020686A1 Novel derivatives of thiopyranopyrrole and preparation thereof
11/18/1992	WO1992020685A1 Novel derivatives of thiopyranopyrrole, their preparation and pharmaceutical compositions containing them
11/18/1992	WO1992020653A1 Novel derivatives of perhydroisoindol, their preparation, and pharmaceutical compositions containing them
11/18/1992	WO1992020648A1 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
11/18/1992	CN1066292A Compounds, named "leustroducsins", their preparation and their therapeutic uses
11/18/1992	CN1066271A 14 beta-h-,14-and 15-ene-11 beta-aryl-4-estrene
11/18/1992	CN1066270A Pharmaceutical compounds
11/18/1992	CN1066269A Treatment of mastitis
11/18/1992	CN1066268A Process for preparation of 4'-demethylepipodophyllotoxin glucoside 4'-phosphates
11/18/1992	CN1066267A Prepn. and application of organo-chromium containing yeast
11/18/1992	CN1066188A Prepn. method for tonic oral liquor
11/18/1992	CN1066186A Pharmaceutical formulation containing dirithromycin
11/18/1992	CN1066184A Optimized tablet formulation
11/18/1992	CN1066170A Glycine anhydride dimethylol as biocide and preservative
11/18/1992	CN1019116B Cardiotonic tricyclic oxazolones and the prepn. therefor
11/18/1992	CN1019115B Synthesis of 5,6-dihydro-6-oxy-11 hydrogen-pyridine (2,3-b) (1,4) benzene dinitroazine
11/18/1992	CN1019113B 3-aryloxy-3-substituted propanamines
11/18/1992	CA2109298A1 New perhydroisoindole derivatives; process for preparing the same and pharmaceutical compositions containing them
11/18/1992	CA2109296A1 New thiopyranopyrrole derivatives; process for preparing the same and pharmaceutical compositions containing them
11/18/1992	CA2109295A1 New thiopyranopyrrole derivatives and process for preparing them
11/18/1992	CA2102811A1 Novel heterocyclic carboxylic acids
11/18/1992	CA2102295A1 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
11/17/1992	WO1992020695A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
11/17/1992	WO1992020372A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
11/17/1992	WO1992020332A1 Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent
11/17/1992	WO1992020323A1 Methods for the administration of drugs
11/17/1992	US5164526 Pleuromutilins
11/17/1992	US5164509 Benzodiazolo analogs
11/17/1992	US5164507 Fungicide
11/17/1992	US5164503 Reduction, hydrolysis
11/17/1992	US5164494 Cephalosporin derivatives
11/17/1992	US5164482 Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
11/17/1992	US5164416 Improved absorption
11/17/1992	US5164415 Amylase inhibitor
11/17/1992	US5164414 Antitumor
11/17/1992	US5164413 Acids, amides, acylhalides
11/17/1992	US5164410 Fumagillol derivatives and pharmaceutical compositions thereof
11/17/1992	US5164407 Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
11/17/1992	US5164406 Method for enhancing transdermal penetration and compositions useful therein
11/17/1992	US5164405 Cardiovascular
11/17/1992	US5164404 Amino acid antagonists
11/17/1992	US5164403 Hypotensive agents, cardiovascular disorders
11/17/1992	US5164401 Method of diuretic treatment with 3,7-diazabicyclo[3,3,1]nonane compounds
11/17/1992	US5164400 Pyrroloquinoline compounds
11/17/1992	US5164398 Ibuprofen-antitussive combinations
11/17/1992	US5164397 Hypotensive
11/17/1992	US5164395 Treatment of herpes, ribonucleotide reductase inhibitor
11/17/1992	US5164394 Cytokinin
11/17/1992	US5164389 Anthelmintic bioconversion products
11/17/1992	US5164386 R(-)3-quinuclidinol derivatives
11/17/1992	US5164382 Bactericides, fungicides, herbicides
11/17/1992	US5164380 Improved solubility and pharmacokinetic properties
11/17/1992	US5164379 Sucralfate/cyclodextrin complexes
11/17/1992	US5164378 Supersulfated heparins
11/17/1992	US5164377 Sulphated glycosaminoglycuronan with antithrombotic activity
11/17/1992	US5164376 Viricides, AIDS
11/17/1992	US5164375 Antifungal agent
11/17/1992	US5164374 Use of oligosaccharides for treatment of arthritis
11/17/1992	US5164371 Inhibitors of human leukocytic elastase
11/17/1992	US5164369 Asparagine, leucine, arginine, cysteine
11/17/1992	US5164367 Method of using copper(ii) containing compounds to accelerate wound healing
11/17/1992	US5164194 Treatment of irritated eye and nose mucous membranes resulting from a cold or allergy
11/17/1992	US5164192 Effervescent composition for oral rehydration
11/17/1992	US5164189 Single layer transdermal drug administration system
11/17/1992	US5164188 Biodegradable ocular implants
11/17/1992	US5164185 Side effect reduction
11/17/1992	US5163898 Localization, irradiation with light
11/17/1992	CA2109315A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
11/17/1992	CA2103040A1 Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent
11/17/1992	CA2087158A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
11/17/1992	CA2068853A1 Substituted carboxy amino azetidinyl pyridone derivatives; process for preparing the same and their use as drugs
11/17/1992	CA2068779A1 Benzofuran derivatives
11/17/1992	CA2068770A1 3-aminopyridazine derivatives active on the central nervous system, method of preparation and pharmaceutical compositions in which they are present
11/17/1992	CA2068766A1 Benzofuran derivatives
11/17/1992	CA2068756A1 Benzofuran derivatives
11/17/1992	CA2068459A1 2-benzazepines with 5-and 6-membered heterocyclic rings
11/17/1992	CA2067314A1 Low solubility drug-coated bead compositions thereof
11/17/1992	CA1310445C Derivatives of aminopimelic acid, process for their preparation and their application as medecines
11/17/1992	CA1310443C Glutamic acid derivatives, their salts, process of preparation, applications as medications, and compositions containing them
11/17/1992	CA1310331C SUBSTITUTED .alpha.-AMINO ACIDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
11/17/1992	CA1310327C Process for the preparation of hydroxyalkylation agents, new agents thus obtained and their use
11/17/1992	CA1310326C Process for the preparation of 1-hydroxy-5-nitroimidazoles
11/17/1992	CA1310324C Quinoline derivatives as anticonvulsive and psychotonic agents
11/17/1992	CA1310322C Cyclohexanedione derivative and a process for producing the same
11/17/1992	CA1310320C Antihypercholesterolemic compounds
11/17/1992	CA1310318C Imidazo(1,2-b)pyridazines, process for their preparation and pharmaceutical compositions in which they are present
11/17/1992	CA1310317C Prodrugs of antihypercholesterolemic compounds
11/17/1992	CA1310272C Ibuprofen sustained release matrix and process
11/17/1992	CA1310271C Antiulcer composition
11/17/1992	CA1310270C Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof
11/17/1992	CA1310269C Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
11/17/1992	CA1310268C Transdermal fertility control system and process
11/16/1992	CA2068696A1 Imine-derived aromatic compounds, process for their preparation and their use in human and veterinary medecine, and in cosmetics
11/16/1992	CA2052696A1 5-//4-/(4',6'-dimethyl 1-2-pyrimidinyl) sulfamoyl / phenyl/ azo/acetylsalicyclic acid
11/15/1992	CA2068598A1 Amidic derivatives of 1-aminooctahydropyrido[2,1-c][1,4]oxazine, process for their preparation and pharmaceutical compounds containing them

1 ... 7233 7234 7235 7236 7237 7238 7239 7240 7241 7242 7243 7244 7245 7246 7247 7248 7249 7250 7251 7252 7253 ... 7860